Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018105988) CONJUGATE HAVING ATTENUATED IMMUNE RESPONSE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/105988 International Application No.: PCT/KR2017/014139
Publication Date: 14.06.2018 International Filing Date: 05.12.2017
IPC:
C07K 14/47 (2006.01) ,C07K 16/18 (2006.01) ,C07K 16/28 (2006.01) ,A61K 47/68 (2017.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
[IPC code unknown for A61K 47/68]
Applicants:
한미약품 주식회사 HANMI PHARM. CO., LTD. [KR/KR]; 경기도 화성시 팔탄면 무하로 214 214, Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536, KR
Inventors:
김진영 KIM, Jin Young; KR
이종수 LEE, Jong Soo; KR
최인영 CHOI, In Young; KR
정성엽 JUNG, Sung Youb; KR
Agent:
손민 SON, Min; KR
Priority Data:
10-2016-016461905.12.2016KR
Title (EN) CONJUGATE HAVING ATTENUATED IMMUNE RESPONSE
(FR) CONJUGUÉ AYANT UNE RÉPONSE IMMUNITAIRE ATTÉNUÉE
(KO) 면역반응이 약화된 결합체
Abstract:
(EN) The present invention relates to a bioactive polypeptide-immunoglobulin Fc conjugate having an attenuated immune response, a method for constructing a conjugate related thereto, a composition for attenuating an immune response, comprising the conjugate, and a method for attenuating an immune response of a bioactive polypeptide. In addition, the present invention relates to a method for maintaining a low level of the intrinsic binding affinity of the conjugate to Fc gamma receptor and/or a complement and a composition containing the conjugate.
(FR) La présente invention concerne un conjugué de polypeptide immunoglobuline Fc bioactif ayant une réponse immunitaire atténuée, un procédé de construction d'un conjugué associé à celui-ci, une composition pour atténuer une réponse immunitaire, comprenant le conjugué, et un procédé pour atténuer une réponse immunitaire d'un polypeptide bioactif. La présente invention concerne en outre, un procédé pour maintenir un faible niveau d'affinité de liaison intrinsèque du conjugué au récepteur Fc gamma et/ou un complément et une composition contenant le conjugué.
(KO) 본 발명은 면역반응이 약화된 생리활성 폴리펩타이드 및 면역글로불린 Fc 결합체 및 이와 관련된 결합체의 제조 방법, 상기 결합체를 포함하는 면역반응 감소용 조성물 및 생리활성 폴리펩타이드의 면역반응 감소 방법에 관한 것이다. 또한, 상기 결합체의 Fc 감마수용체 및/또는 보체와의 고유 결합력 저하를 유지시키는 방법 및 상기 결합체를 포함하는 조성물에 관한 것이다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)